# CrowdStrike timeline

entity: /record/crowdstrike.md  
id: ent_crowdstrike  

CrowdStrike's timeline holds 251 claims from 2017 to 2026: 243 money & deals, 8 other. 8 are undated. The latest took effect on August 20, 2026.

Kinds: People 0 (/timelines/crowdstrike.md?kind=people) · Money & deals 243 (/timelines/crowdstrike.md?kind=money) · Products 0 (/timelines/crowdstrike.md?kind=products) · Models 0 (/timelines/crowdstrike.md?kind=models) · Other 8 (/timelines/crowdstrike.md?kind=other)  
Format: date | kind | predicate | value | status | claim.

## 2017

- 2017-01-31 to 2018-01-31 | money | total_equity | -243,453,000 United States dollar | superseded | [clm_3A651F954461](/claim/clm_3A651F954461.md)

## 2018

- 2018-01-31 to 2019-01-31 | money | net_income | -135,490,000 United States dollar | superseded | [clm_D55617E978CD](/claim/clm_D55617E978CD.md)
- 2018-01-31 to 2019-01-31 | money | operating_income | -131,440,000 United States dollar | superseded | [clm_DD63FFEC27DF](/claim/clm_DD63FFEC27DF.md)
- 2018-01-31 to 2019-01-31 | money | research_and_development | 58,887,000 United States dollar | superseded | [clm_704A6568E89F](/claim/clm_704A6568E89F.md)
- 2018-01-31 to 2019-01-31 | money | revenue | 118,752,000 United States dollar | superseded | [clm_2C71B39556CD](/claim/clm_2C71B39556CD.md)
- 2018-01-31 to 2018-04-30 | money | total_equity | -369,474,000 United States dollar | superseded | [clm_2D7194665A46](/claim/clm_2D7194665A46.md)
- 2018-04-30 to 2018-07-31 | money | quarterly_net_income | -33,617,000 United States dollar | superseded | [clm_C6CE3A2DEB08](/claim/clm_C6CE3A2DEB08.md)
- 2018-04-30 to 2018-07-31 | money | quarterly_operating_income | -33,114,000 United States dollar | superseded | [clm_C6816E0B4F61](/claim/clm_C6816E0B4F61.md)
- 2018-04-30 to 2018-07-31 | money | quarterly_research_and_development | 17,615,000 United States dollar | superseded | [clm_F51E058EEC2D](/claim/clm_F51E058EEC2D.md)
- 2018-04-30 to 2018-07-31 | money | quarterly_revenue | 47,289,000 United States dollar | superseded | [clm_11B11DFDCC6B](/claim/clm_11B11DFDCC6B.md)
- 2018-04-30 to 2018-07-31 | money | total_equity | -400,939,000 United States dollar | superseded | [clm_0A337713E9C4](/claim/clm_0A337713E9C4.md)
- 2018-07-31 to 2018-10-31 | money | quarterly_net_income | -32,877,000 United States dollar | superseded | [clm_8EB4FD3CE8F7](/claim/clm_8EB4FD3CE8F7.md)
- 2018-07-31 to 2018-10-31 | money | quarterly_operating_income | -30,427,000 United States dollar | superseded | [clm_D1E33DFEE2A6](/claim/clm_D1E33DFEE2A6.md)
- 2018-07-31 to 2018-10-31 | money | quarterly_research_and_development | 18,963,000 United States dollar | superseded | [clm_CDCFFA1EB544](/claim/clm_CDCFFA1EB544.md)
- 2018-07-31 to 2018-10-31 | money | quarterly_revenue | 55,701,000 United States dollar | superseded | [clm_57BD2BB7962D](/claim/clm_57BD2BB7962D.md)
- 2018-07-31 to 2018-10-31 | money | total_equity | -433,429,000 United States dollar | superseded | [clm_1BCF70E0C5B5](/claim/clm_1BCF70E0C5B5.md)
- 2018-10-31 to 2019-04-30 | money | quarterly_net_income | -42,323,000 United States dollar | superseded | [clm_06F428AE3711](/claim/clm_06F428AE3711.md)
- 2018-10-31 to 2019-04-30 | money | quarterly_operating_income | -42,091,000 United States dollar | superseded | [clm_B929F45EB343](/claim/clm_B929F45EB343.md)
- 2018-10-31 to 2019-04-30 | money | quarterly_research_and_development | 25,968,000 United States dollar | superseded | [clm_659CB143CD96](/claim/clm_659CB143CD96.md)
- 2018-10-31 to 2019-04-30 | money | quarterly_revenue | 66,379,000 United States dollar | superseded | [clm_6BD92B9A4CE3](/claim/clm_6BD92B9A4CE3.md)
- 2018-10-31 to 2019-01-31 | money | total_equity | -461,353,000 United States dollar | superseded | [clm_A91EB676A1EB](/claim/clm_A91EB676A1EB.md)

## 2019

- 2019-01-31 to 2019-04-30 | money | cash_and_equivalents | 88,408,000 United States dollar | superseded | [clm_E40B4BFE9DBC](/claim/clm_E40B4BFE9DBC.md)
- 2019-01-31 to 2020-01-31 | money | net_income | -140,077,000 United States dollar | superseded | [clm_71D32186826F](/claim/clm_71D32186826F.md)
- 2019-01-31 to 2020-01-31 | money | operating_income | -136,864,000 United States dollar | superseded | [clm_55C2F2A727C5](/claim/clm_55C2F2A727C5.md)
- 2019-01-31 to 2020-01-31 | money | research_and_development | 84,551,000 United States dollar | superseded | [clm_D2B47C87FF3A](/claim/clm_D2B47C87FF3A.md)
- 2019-01-31 to 2020-01-31 | money | revenue | 249,824,000 United States dollar | superseded | [clm_A6293492AC73](/claim/clm_A6293492AC73.md)
- 2019-01-31 to 2019-04-30 | money | total_assets | 433,219,000 United States dollar | superseded | [clm_9376BAB8E744](/claim/clm_9376BAB8E744.md)
- 2019-01-31 to 2019-04-30 | money | total_equity | -487,793,000 United States dollar | superseded | [clm_9492797E0A45](/claim/clm_9492797E0A45.md)
- 2019-04-30 to 2019-07-31 | money | cash_and_equivalents | 92,993,000 United States dollar | superseded | [clm_B7E81BE9B0EC](/claim/clm_B7E81BE9B0EC.md)
- 2019-04-30 to 2019-07-31 | money | quarterly_net_income | -25,977,000 United States dollar | superseded | [clm_3BEA32E83680](/claim/clm_3BEA32E83680.md)
- 2019-04-30 to 2019-07-31 | money | quarterly_operating_income | -25,775,000 United States dollar | superseded | [clm_41FDD0153D9A](/claim/clm_41FDD0153D9A.md)
- 2019-04-30 to 2019-07-31 | money | quarterly_research_and_development | 23,875,000 United States dollar | superseded | [clm_D011B365A1B9](/claim/clm_D011B365A1B9.md)
- 2019-04-30 to 2019-07-31 | money | quarterly_revenue | 96,077,000 United States dollar | superseded | [clm_90749C735671](/claim/clm_90749C735671.md)
- 2019-04-30 to 2019-07-31 | money | total_assets | 457,361,000 United States dollar | superseded | [clm_160B16E38883](/claim/clm_160B16E38883.md)
- 2019-04-30 to 2019-07-31 | money | total_equity | -485,177,000 United States dollar | superseded | [clm_9F691923970D](/claim/clm_9F691923970D.md)
- 2019-07-31 to 2019-10-31 | money | cash_and_equivalents | 732,808,000 United States dollar | superseded | [clm_6D05B588911E](/claim/clm_6D05B588911E.md)
- 2019-07-31 to 2019-10-31 | money | quarterly_net_income | -51,889,000 United States dollar | superseded | [clm_6FBE274B8904](/claim/clm_6FBE274B8904.md)
- 2019-07-31 to 2019-10-31 | money | quarterly_operating_income | -50,639,000 United States dollar | superseded | [clm_DA6FE720A3D6](/claim/clm_DA6FE720A3D6.md)
- 2019-07-31 to 2019-10-31 | money | quarterly_research_and_development | 31,630,000 United States dollar | superseded | [clm_942BD1665D43](/claim/clm_942BD1665D43.md)
- 2019-07-31 to 2019-10-31 | money | quarterly_revenue | 108,108,000 United States dollar | superseded | [clm_9414696205C1](/claim/clm_9414696205C1.md)
- 2019-07-31 to 2019-10-31 | money | total_assets | 1,171,586,000 United States dollar | superseded | [clm_AFA4B469588E](/claim/clm_AFA4B469588E.md)
- 2019-07-31 to 2019-10-31 | money | total_equity | 728,097,000 United States dollar | superseded | [clm_34EAF9A7856A](/claim/clm_34EAF9A7856A.md)
- 2019-10-31 to 2020-01-31 | money | cash_and_equivalents | 743,605,000 United States dollar | superseded | [clm_9D29B0BD62B4](/claim/clm_9D29B0BD62B4.md)
- 2019-10-31 to 2020-04-30 | money | quarterly_net_income | -35,505,000 United States dollar | superseded | [clm_54ADA47CB192](/claim/clm_54ADA47CB192.md)
- 2019-10-31 to 2020-04-30 | money | quarterly_operating_income | -38,518,000 United States dollar | superseded | [clm_E5D90ACAA772](/claim/clm_E5D90ACAA772.md)
- 2019-10-31 to 2020-04-30 | money | quarterly_research_and_development | 35,992,000 United States dollar | superseded | [clm_823749E9F33E](/claim/clm_823749E9F33E.md)
- 2019-10-31 to 2020-04-30 | money | quarterly_revenue | 125,119,000 United States dollar | superseded | [clm_4030FF63F822](/claim/clm_4030FF63F822.md)
- 2019-10-31 to 2020-01-31 | money | total_assets | 1,256,054,000 United States dollar | superseded | [clm_D6072E591428](/claim/clm_D6072E591428.md)
- 2019-10-31 to 2020-01-31 | money | total_equity | 717,042,000 United States dollar | superseded | [clm_4FF4DB45BE55](/claim/clm_4FF4DB45BE55.md)

## 2020

- 2020-01-31 to 2020-04-30 | money | cash_and_equivalents | 264,798,000 United States dollar | superseded | [clm_BA1E88A77DE2](/claim/clm_BA1E88A77DE2.md)
- 2020-01-31 to 2021-01-31 | money | net_income | -141,779,000 United States dollar | superseded | [clm_B32D629177F7](/claim/clm_B32D629177F7.md)
- 2020-01-31 to 2021-01-31 | money | operating_income | -146,065,000 United States dollar | superseded | [clm_5B648132352C](/claim/clm_5B648132352C.md)
- 2020-01-31 to 2021-01-31 | money | research_and_development | 130,188,000 United States dollar | superseded | [clm_4C217C929B93](/claim/clm_4C217C929B93.md)
- 2020-01-31 to 2021-01-31 | money | revenue | 481,413,000 United States dollar | superseded | [clm_DDCC88F3F84D](/claim/clm_DDCC88F3F84D.md)
- 2020-01-31 to 2020-04-30 | money | total_assets | 1,404,906,000 United States dollar | superseded | [clm_080370AE4A5C](/claim/clm_080370AE4A5C.md)
- 2020-01-31 to 2020-04-30 | money | total_equity | 742,107,000 United States dollar | superseded | [clm_B6921D61E236](/claim/clm_B6921D61E236.md)
- 2020-04-30 to 2020-07-31 | money | cash_and_equivalents | 1,004,991,000 United States dollar | superseded | [clm_2277CB977B06](/claim/clm_2277CB977B06.md)
- 2020-04-30 to 2020-07-31 | money | quarterly_net_income | -19,222,000 United States dollar | superseded | [clm_67D61A2CB339](/claim/clm_67D61A2CB339.md)
- 2020-04-30 to 2020-07-31 | money | quarterly_operating_income | -22,576,000 United States dollar | superseded | [clm_447498F26B85](/claim/clm_447498F26B85.md)
- 2020-04-30 to 2020-07-31 | money | quarterly_research_and_development | 40,578,000 United States dollar | superseded | [clm_0973D867A01C](/claim/clm_0973D867A01C.md)
- 2020-04-30 to 2020-07-31 | money | quarterly_revenue | 178,078,000 United States dollar | superseded | [clm_C1627D4F260A](/claim/clm_C1627D4F260A.md)
- 2020-04-30 to 2020-07-31 | money | total_assets | 1,519,396,000 United States dollar | superseded | [clm_A02BF9DD8A61](/claim/clm_A02BF9DD8A61.md)
- 2020-04-30 to 2020-07-31 | money | total_equity | 752,153,000 United States dollar | superseded | [clm_66154C17CAE2](/claim/clm_66154C17CAE2.md)
- 2020-07-31 to 2020-10-31 | money | cash_and_equivalents | 1,064,734,000 United States dollar | superseded | [clm_0FDEE1567D36](/claim/clm_0FDEE1567D36.md)
- 2020-07-31 to 2020-10-31 | money | quarterly_net_income | -29,874,000 United States dollar | superseded | [clm_BED51374BC86](/claim/clm_BED51374BC86.md)
- 2020-07-31 to 2020-10-31 | money | quarterly_operating_income | -29,991,000 United States dollar | superseded | [clm_90DCA3B450C9](/claim/clm_90DCA3B450C9.md)
- 2020-07-31 to 2020-10-31 | money | quarterly_research_and_development | 50,483,000 United States dollar | superseded | [clm_6C54951BB7E9](/claim/clm_6C54951BB7E9.md)
- 2020-07-31 to 2020-10-31 | money | quarterly_revenue | 198,971,000 United States dollar | superseded | [clm_05464245ABCF](/claim/clm_05464245ABCF.md)
- 2020-07-31 to 2020-10-31 | money | total_assets | 1,616,952,000 United States dollar | superseded | [clm_663EBE19D0B4](/claim/clm_663EBE19D0B4.md)
- 2020-07-31 to 2020-10-31 | money | total_equity | 790,965,000 United States dollar | superseded | [clm_62F184B94E29](/claim/clm_62F184B94E29.md)
- 2020-10-31 to 2021-01-31 | money | cash_and_equivalents | 1,059,926,000 United States dollar | superseded | [clm_32C680892F3B](/claim/clm_32C680892F3B.md)
- 2020-10-31 to 2021-04-30 | money | quarterly_net_income | -24,531,000 United States dollar | superseded | [clm_D9F670387833](/claim/clm_D9F670387833.md)
- 2020-10-31 to 2021-04-30 | money | quarterly_operating_income | -24,159,000 United States dollar | superseded | [clm_21B3154DED34](/claim/clm_21B3154DED34.md)
- 2020-10-31 to 2021-04-30 | money | quarterly_research_and_development | 57,539,000 United States dollar | superseded | [clm_7642637254FA](/claim/clm_7642637254FA.md)
- 2020-10-31 to 2021-04-30 | money | quarterly_revenue | 232,460,000 United States dollar | superseded | [clm_E8EDA399D0F1](/claim/clm_E8EDA399D0F1.md)
- 2020-10-31 to 2021-01-31 | money | total_assets | 1,749,509,000 United States dollar | superseded | [clm_21A9008F5DE0](/claim/clm_21A9008F5DE0.md)
- 2020-10-31 to 2021-01-31 | money | total_equity | 813,485,000 United States dollar | superseded | [clm_073252A761A1](/claim/clm_073252A761A1.md)

## 2021

- 2021-01-31 to 2021-04-30 | money | cash_and_equivalents | 1,918,608,000 United States dollar | superseded | [clm_831C0F4658A5](/claim/clm_831C0F4658A5.md)
- 2021-01-31 to 2022-01-31 | money | net_income | -92,629,000 United States dollar | superseded | [clm_5F08EBE51D90](/claim/clm_5F08EBE51D90.md)
- 2021-01-31 to 2022-01-31 | money | operating_income | -92,529,000 United States dollar | superseded | [clm_B9D8E2E2274B](/claim/clm_B9D8E2E2274B.md)
- 2021-01-31 to 2022-01-31 | money | research_and_development | 214,670,000 United States dollar | superseded | [clm_B7A882B963CF](/claim/clm_B7A882B963CF.md)
- 2021-01-31 to 2022-01-31 | money | revenue | 874,438,000 United States dollar | superseded | [clm_73859C4922D4](/claim/clm_73859C4922D4.md)
- 2021-01-31 to 2021-04-30 | money | total_assets | 2,732,533,000 United States dollar | superseded | [clm_D3E49E963F95](/claim/clm_D3E49E963F95.md)
- 2021-01-31 to 2021-04-30 | money | total_equity | 870,574,000 United States dollar | superseded | [clm_A13A4C82982D](/claim/clm_A13A4C82982D.md)
- 2021-04-30 to 2021-07-31 | money | cash_and_equivalents | 1,684,997,000 United States dollar | superseded | [clm_D1EF92B2FDA1](/claim/clm_D1EF92B2FDA1.md)
- 2021-04-30 to 2021-07-31 | money | quarterly_net_income | -85,049,000 United States dollar | superseded | [clm_79C7C640C152](/claim/clm_79C7C640C152.md)
- 2021-04-30 to 2021-07-31 | money | quarterly_operating_income | -31,347,000 United States dollar | superseded | [clm_CA6A3C83E217](/claim/clm_CA6A3C83E217.md)
- 2021-04-30 to 2021-07-31 | money | quarterly_research_and_development | 78,180,000 United States dollar | superseded | [clm_1CE683F2BF79](/claim/clm_1CE683F2BF79.md)
- 2021-04-30 to 2021-07-31 | money | quarterly_revenue | 302,843,000 United States dollar | superseded | [clm_F324B73FB54D](/claim/clm_F324B73FB54D.md)
- 2021-04-30 to 2021-07-31 | money | total_assets | 2,881,171,000 United States dollar | superseded | [clm_BD07D2992762](/claim/clm_BD07D2992762.md)
- 2021-04-30 to 2021-07-31 | money | total_equity | 849,264,000 United States dollar | superseded | [clm_D2127919E393](/claim/clm_D2127919E393.md)
- 2021-07-31 to 2021-10-31 | money | cash_and_equivalents | 1,787,051,000 United States dollar | superseded | [clm_A9A32F603780](/claim/clm_A9A32F603780.md)
- 2021-07-31 to 2021-10-31 | money | quarterly_net_income | -57,318,000 United States dollar | superseded | [clm_E03F75157793](/claim/clm_E03F75157793.md)
- 2021-07-31 to 2021-10-31 | money | quarterly_operating_income | -47,403,000 United States dollar | superseded | [clm_7936B82C8375](/claim/clm_7936B82C8375.md)
- 2021-07-31 to 2021-10-31 | money | quarterly_research_and_development | 90,455,000 United States dollar | superseded | [clm_82F616F318A4](/claim/clm_82F616F318A4.md)
- 2021-07-31 to 2021-10-31 | money | quarterly_revenue | 337,690,000 United States dollar | superseded | [clm_AF7977A9EA61](/claim/clm_AF7977A9EA61.md)
- 2021-07-31 to 2021-10-31 | money | total_assets | 3,136,045,000 United States dollar | superseded | [clm_730E0136C945](/claim/clm_730E0136C945.md)
- 2021-07-31 to 2021-10-31 | money | total_equity | 904,268,000 United States dollar | superseded | [clm_944749BDFB23](/claim/clm_944749BDFB23.md)
- 2021-10-31 to 2022-01-31 | money | cash_and_equivalents | 1,907,508,000 United States dollar | superseded | [clm_18311B9BBD14](/claim/clm_18311B9BBD14.md)
- 2021-10-31 to 2022-04-30 | money | quarterly_net_income | -50,455,000 United States dollar | superseded | [clm_EE28DAF36D91](/claim/clm_EE28DAF36D91.md)
- 2021-10-31 to 2022-04-30 | money | quarterly_operating_income | -40,264,000 United States dollar | superseded | [clm_3BECBB7A9233](/claim/clm_3BECBB7A9233.md)
- 2021-10-31 to 2022-04-30 | money | quarterly_research_and_development | 97,630,000 United States dollar | superseded | [clm_9FEACDC4B693](/claim/clm_9FEACDC4B693.md)
- 2021-10-31 to 2022-04-30 | money | quarterly_revenue | 380,051,000 United States dollar | superseded | [clm_7C40ACAF6D07](/claim/clm_7C40ACAF6D07.md)
- 2021-10-31 to 2022-01-31 | money | total_assets | 3,299,617,000 United States dollar | superseded | [clm_CD5E9921876D](/claim/clm_CD5E9921876D.md)
- 2021-10-31 to 2022-01-31 | money | total_equity | 948,182,000 United States dollar | superseded | [clm_57C0F90EF0DF](/claim/clm_57C0F90EF0DF.md)

## 2022

- 2022-01-31 to 2022-04-30 | money | cash_and_equivalents | 1,996,633,000 United States dollar | superseded | [clm_002681FF2ED3](/claim/clm_002681FF2ED3.md)
- 2022-01-31 to 2023-01-31 | money | net_income | -234,802,000 United States dollar | superseded | [clm_28998C36EA38](/claim/clm_28998C36EA38.md)
- 2022-01-31 to 2023-01-31 | money | operating_income | -142,548,000 United States dollar | superseded | [clm_D06C9FD0C785](/claim/clm_D06C9FD0C785.md)
- 2022-01-31 to 2023-01-31 | money | research_and_development | 371,283,000 United States dollar | superseded | [clm_539CBE2ACE1F](/claim/clm_539CBE2ACE1F.md)
- 2022-01-31 to 2023-01-31 | money | revenue | 1,451,594,000 United States dollar | superseded | [clm_F7EB0737632A](/claim/clm_F7EB0737632A.md)
- 2022-01-31 to 2022-04-30 | money | total_assets | 3,618,381,000 United States dollar | superseded | [clm_37128D51F161](/claim/clm_37128D51F161.md)
- 2022-01-31 to 2022-04-30 | money | total_equity | 1,025,764,000 United States dollar | superseded | [clm_C90FBD38B784](/claim/clm_C90FBD38B784.md)
- 2022-04-30 to 2022-07-31 | money | cash_and_equivalents | 2,152,736,000 United States dollar | superseded | [clm_E7E2C59682B8](/claim/clm_E7E2C59682B8.md)
- 2022-04-30 to 2022-07-31 | money | quarterly_net_income | -31,523,000 United States dollar | superseded | [clm_36D162A63466](/claim/clm_36D162A63466.md)
- 2022-04-30 to 2022-07-31 | money | quarterly_operating_income | -23,883,000 United States dollar | superseded | [clm_7F67BFD49D7D](/claim/clm_7F67BFD49D7D.md)
- 2022-04-30 to 2022-07-31 | money | quarterly_research_and_development | 123,399,000 United States dollar | superseded | [clm_972E8F8239D9](/claim/clm_972E8F8239D9.md)
- 2022-04-30 to 2022-07-31 | money | quarterly_revenue | 487,834,000 United States dollar | superseded | [clm_64F85DDC3646](/claim/clm_64F85DDC3646.md)
- 2022-04-30 to 2022-07-31 | money | total_assets | 3,835,835,000 United States dollar | superseded | [clm_7D587AD55173](/claim/clm_7D587AD55173.md)
- 2022-04-30 to 2022-07-31 | money | total_equity | 1,102,541,000 United States dollar | superseded | [clm_0017C18A9371](/claim/clm_0017C18A9371.md)
- 2022-07-31 to 2022-10-31 | money | cash_and_equivalents | 2,318,858,000 United States dollar | superseded | [clm_D749451CA343](/claim/clm_D749451CA343.md)
- 2022-07-31 to 2022-10-31 | money | quarterly_net_income | -49,285,000 United States dollar | superseded | [clm_A746147DBA4C](/claim/clm_A746147DBA4C.md)
- 2022-07-31 to 2022-10-31 | money | quarterly_operating_income | -48,307,000 United States dollar | superseded | [clm_B26DBEACC2EC](/claim/clm_B26DBEACC2EC.md)
- 2022-07-31 to 2022-10-31 | money | quarterly_research_and_development | 137,864,000 United States dollar | superseded | [clm_34A0554E4963](/claim/clm_34A0554E4963.md)
- 2022-07-31 to 2022-10-31 | money | quarterly_revenue | 535,153,000 United States dollar | superseded | [clm_45DA66321C7E](/claim/clm_45DA66321C7E.md)
- 2022-07-31 to 2022-10-31 | money | total_assets | 4,154,236,000 United States dollar | superseded | [clm_7800B98C0847](/claim/clm_7800B98C0847.md)
- 2022-07-31 to 2022-10-31 | money | total_equity | 1,225,419,000 United States dollar | superseded | [clm_DB4861E31E56](/claim/clm_DB4861E31E56.md)
- 2022-10-31 to 2023-01-31 | money | cash_and_equivalents | 2,466,551,000 United States dollar | superseded | [clm_38E553F6D65C](/claim/clm_38E553F6D65C.md)
- 2022-10-31 to 2023-04-30 | money | quarterly_net_income | -54,956,000 United States dollar | superseded | [clm_A9100BEACE46](/claim/clm_A9100BEACE46.md)
- 2022-10-31 to 2023-04-30 | money | quarterly_operating_income | -56,422,000 United States dollar | superseded | [clm_E40BD6D91564](/claim/clm_E40BD6D91564.md)
- 2022-10-31 to 2023-04-30 | money | quarterly_research_and_development | 155,256,000 United States dollar | superseded | [clm_F8B1414D9220](/claim/clm_F8B1414D9220.md)
- 2022-10-31 to 2023-04-30 | money | quarterly_revenue | 580,882,000 United States dollar | superseded | [clm_5B2607EEAEDF](/claim/clm_5B2607EEAEDF.md)
- 2022-10-31 to 2023-01-31 | money | total_assets | 4,469,443,000 United States dollar | superseded | [clm_3E2274A123D8](/claim/clm_3E2274A123D8.md)
- 2022-10-31 to 2023-01-31 | money | total_equity | 1,314,289,000 United States dollar | superseded | [clm_D49ED0EEBA4D](/claim/clm_D49ED0EEBA4D.md)

## 2023

- 2023-01-31 to 2023-04-30 | money | cash_and_equivalents | 2,455,369,000 United States dollar | superseded | [clm_BAC0C53C12C6](/claim/clm_BAC0C53C12C6.md)
- 2023-01-31 to 2024-01-31 | money | net_income | -183,245,000 United States dollar | superseded | [clm_32AFBABB38B0](/claim/clm_32AFBABB38B0.md)
- 2023-01-31 to 2024-01-31 | money | operating_income | -190,112,000 United States dollar | superseded | [clm_3E78D25E6578](/claim/clm_3E78D25E6578.md)
- 2023-01-31 to 2024-01-31 | money | research_and_development | 608,364,000 United States dollar | superseded | [clm_6069D7168CC9](/claim/clm_6069D7168CC9.md)
- 2023-01-31 to 2024-01-31 | money | revenue | 2,241,236,000 United States dollar | superseded | [clm_89445CDB6F56](/claim/clm_89445CDB6F56.md)
- 2023-01-31 to 2023-04-30 | money | total_assets | 5,026,540,000 United States dollar | superseded | [clm_CADEACD4BDFC](/claim/clm_CADEACD4BDFC.md)
- 2023-01-31 to 2023-04-30 | money | total_equity | 1,463,641,000 United States dollar | superseded | [clm_22AD1F0B83E9](/claim/clm_22AD1F0B83E9.md)
- 2023-04-30 to 2023-07-31 | money | cash_and_equivalents | 2,829,677,000 United States dollar | superseded | [clm_CD5F1D0E3F4F](/claim/clm_CD5F1D0E3F4F.md)
- 2023-04-30 to 2023-07-31 | money | quarterly_net_income | 491,000 United States dollar | superseded | [clm_4E6F295FA34C](/claim/clm_4E6F295FA34C.md)
- 2023-04-30 to 2023-07-31 | money | quarterly_operating_income | -19,456,000 United States dollar | superseded | [clm_6D60C30FF3FB](/claim/clm_6D60C30FF3FB.md)
- 2023-04-30 to 2023-07-31 | money | quarterly_research_and_development | 179,065,000 United States dollar | superseded | [clm_EDB0F408F626](/claim/clm_EDB0F408F626.md)
- 2023-04-30 to 2023-07-31 | money | quarterly_revenue | 692,580,000 United States dollar | superseded | [clm_6A13594895A7](/claim/clm_6A13594895A7.md)
- 2023-04-30 to 2023-07-31 | money | total_assets | 5,137,858,000 United States dollar | superseded | [clm_BF3F94E0DFC5](/claim/clm_BF3F94E0DFC5.md)
- 2023-04-30 to 2023-07-31 | money | total_equity | 1,605,301,000 United States dollar | superseded | [clm_20991FC541C8](/claim/clm_20991FC541C8.md)
- 2023-07-31 to 2023-10-31 | money | cash_and_equivalents | 3,167,215,000 United States dollar | superseded | [clm_73D81BFECE6D](/claim/clm_73D81BFECE6D.md)
- 2023-07-31 to 2023-10-31 | money | quarterly_net_income | 8,472,000 United States dollar | superseded | [clm_02CFB9C3EA00](/claim/clm_02CFB9C3EA00.md)
- 2023-07-31 to 2023-10-31 | money | quarterly_operating_income | -15,373,000 United States dollar | superseded | [clm_A5E445A9D342](/claim/clm_A5E445A9D342.md)
- 2023-07-31 to 2023-10-31 | money | quarterly_research_and_development | 179,362,000 United States dollar | superseded | [clm_027EAAE06C10](/claim/clm_027EAAE06C10.md)
- 2023-07-31 to 2023-10-31 | money | quarterly_revenue | 731,626,000 United States dollar | superseded | [clm_50FA71FE0F68](/claim/clm_50FA71FE0F68.md)
- 2023-07-31 to 2023-10-31 | money | total_assets | 5,520,458,000 United States dollar | superseded | [clm_3187C47CE367](/claim/clm_3187C47CE367.md)
- 2023-07-31 to 2023-10-31 | money | total_equity | 1,838,207,000 United States dollar | superseded | [clm_7B506EB49CA9](/claim/clm_7B506EB49CA9.md)
- 2023-10-31 to 2024-01-31 | money | cash_and_equivalents | 2,968,872,000 United States dollar | superseded | [clm_24C306908229](/claim/clm_24C306908229.md)
- 2023-10-31 to 2024-04-30 | money | quarterly_net_income | 26,665,000 United States dollar | superseded | [clm_B26B790C474D](/claim/clm_B26B790C474D.md)
- 2023-10-31 to 2024-04-30 | money | quarterly_operating_income | 3,163,000 United States dollar | superseded | [clm_0B1EE0D31E2F](/claim/clm_0B1EE0D31E2F.md)
- 2023-10-31 to 2024-04-30 | money | quarterly_research_and_development | 196,072,000 United States dollar | superseded | [clm_C0959D7CB859](/claim/clm_C0959D7CB859.md)
- 2023-10-31 to 2024-04-30 | money | quarterly_revenue | 786,014,000 United States dollar | superseded | [clm_92F2CA4930BE](/claim/clm_92F2CA4930BE.md)
- 2023-10-31 to 2024-01-31 | money | total_assets | 5,831,056,000 United States dollar | superseded | [clm_0E415DFB11F9](/claim/clm_0E415DFB11F9.md)
- 2023-10-31 to 2024-01-31 | money | total_equity | 2,028,950,000 United States dollar | superseded | [clm_059FE5D048EB](/claim/clm_059FE5D048EB.md)

## 2024

- 2024-01-31 to 2024-04-30 | money | cash_and_equivalents | 3,375,069,000 United States dollar | superseded | [clm_687CB81AD1FD](/claim/clm_687CB81AD1FD.md)
- 2024-01-31 to 2025-01-31 | money | net_income | 89,327,000 United States dollar | superseded | [clm_65AB2AEA1BCE](/claim/clm_65AB2AEA1BCE.md)
- 2024-01-31 to 2025-01-31 | money | operating_income | -1,995,000 United States dollar | superseded | [clm_014DCA649A8E](/claim/clm_014DCA649A8E.md)
- 2024-01-31 to 2025-01-31 | money | research_and_development | 768,497,000 United States dollar | superseded | [clm_6F09B21D55E2](/claim/clm_6F09B21D55E2.md)
- 2024-01-31 to 2025-01-31 | money | revenue | 3,055,555,000 United States dollar | superseded | [clm_9F4726676156](/claim/clm_9F4726676156.md)
- 2024-01-31 to 2024-04-30 | money | total_assets | 6,646,520,000 United States dollar | superseded | [clm_2D754A46CB23](/claim/clm_2D754A46CB23.md)
- 2024-01-31 to 2024-04-30 | money | total_equity | 2,303,950,000 United States dollar | superseded | [clm_99027F47EA78](/claim/clm_99027F47EA78.md)
- 2024-04-30 to 2024-07-31 | money | cash_and_equivalents | 3,702,437,000 United States dollar | superseded | [clm_9001F1341731](/claim/clm_9001F1341731.md)
- 2024-04-30 to 2024-07-31 | money | quarterly_net_income | 42,820,000 United States dollar | superseded | [clm_3A1B2CA8C159](/claim/clm_3A1B2CA8C159.md)
- 2024-04-30 to 2024-07-31 | money | quarterly_operating_income | 6,936,000 United States dollar | superseded | [clm_6D861CFFF535](/claim/clm_6D861CFFF535.md)
- 2024-04-30 to 2024-07-31 | money | quarterly_research_and_development | 235,249,000 United States dollar | superseded | [clm_F4CF74509730](/claim/clm_F4CF74509730.md)
- 2024-04-30 to 2024-07-31 | money | quarterly_revenue | 921,036,000 United States dollar | superseded | [clm_B15F50B35054](/claim/clm_B15F50B35054.md)
- 2024-04-30 to 2024-07-31 | money | total_assets | 6,841,985,000 United States dollar | superseded | [clm_99A130AA3181](/claim/clm_99A130AA3181.md)
- 2024-04-30 to 2024-07-31 | money | total_equity | 2,535,540,000 United States dollar | superseded | [clm_6AAE90D7ABCB](/claim/clm_6AAE90D7ABCB.md)
- 2024-07-31 to 2024-10-31 | money | cash_and_equivalents | 4,038,536,000 United States dollar | superseded | [clm_202F6A293C01](/claim/clm_202F6A293C01.md)
- 2024-07-31 to 2024-10-31 | money | quarterly_net_income | 47,013,000 United States dollar | superseded | [clm_86053A8D0A7E](/claim/clm_86053A8D0A7E.md)
- 2024-07-31 to 2024-10-31 | money | quarterly_operating_income | 13,658,000 United States dollar | superseded | [clm_9150CA89FB90](/claim/clm_9150CA89FB90.md)
- 2024-07-31 to 2024-10-31 | money | quarterly_research_and_development | 250,908,000 United States dollar | superseded | [clm_09E91E3C0439](/claim/clm_09E91E3C0439.md)
- 2024-07-31 to 2024-10-31 | money | quarterly_revenue | 963,872,000 United States dollar | superseded | [clm_A8265B3E5BF7](/claim/clm_A8265B3E5BF7.md)
- 2024-07-31 to 2024-10-31 | money | total_assets | 7,202,474,000 United States dollar | superseded | [clm_227B55850BEB](/claim/clm_227B55850BEB.md)
- 2024-07-31 to 2024-10-31 | money | total_equity | 2,852,915,000 United States dollar | superseded | [clm_CFA154895712](/claim/clm_CFA154895712.md)
- 2024-10-31 to 2025-01-31 | money | cash_and_equivalents | 4,260,324,000 United States dollar | superseded | [clm_F52981D14685](/claim/clm_F52981D14685.md)
- 2024-10-31 to 2025-04-30 | money | quarterly_net_income | -16,822,000 United States dollar | superseded | [clm_7A7B0CFB8838](/claim/clm_7A7B0CFB8838.md)
- 2024-10-31 to 2025-04-30 | money | quarterly_operating_income | -55,723,000 United States dollar | superseded | [clm_0935CDB17C96](/claim/clm_0935CDB17C96.md)
- 2024-10-31 to 2025-04-30 | money | quarterly_research_and_development | 275,602,000 United States dollar | superseded | [clm_7BC80E32F5C2](/claim/clm_7BC80E32F5C2.md)
- 2024-10-31 to 2025-04-30 | money | quarterly_revenue | 1,010,178,000 United States dollar | superseded | [clm_BF0C9E1EB7B1](/claim/clm_BF0C9E1EB7B1.md)
- 2024-10-31 to 2025-01-31 | money | total_assets | 7,782,958,000 United States dollar | superseded | [clm_507406D77245](/claim/clm_507406D77245.md)
- 2024-10-31 to 2025-01-31 | money | total_equity | 3,057,933,000 United States dollar | superseded | [clm_29E751DD9D71](/claim/clm_29E751DD9D71.md)

## 2025

- 2025-01-31 to 2025-04-30 | money | cash_and_equivalents | 4,323,295,000 United States dollar | superseded | [clm_7AED26E5E902](/claim/clm_7AED26E5E902.md)
- 2025-01-31 to 2026-01-31 | money | net_income | -19,271,000 United States dollar | superseded | [clm_4A961474014A](/claim/clm_4A961474014A.md)
- 2025-01-31 to 2026-01-31 | money | operating_income | -120,430,000 United States dollar | superseded | [clm_6BD49876F8EC](/claim/clm_6BD49876F8EC.md)
- 2025-01-31 to 2026-01-31 | money | research_and_development | 1,076,901,000 United States dollar | superseded | [clm_60DFEFBA3E04](/claim/clm_60DFEFBA3E04.md)
- 2025-01-31 to 2026-01-31 | money | revenue | 3,953,624,000 United States dollar | superseded | [clm_44119DDD0B63](/claim/clm_44119DDD0B63.md)
- 2025-01-31 to 2025-04-30 | money | total_assets | 8,701,578,000 United States dollar | superseded | [clm_98330634E95A](/claim/clm_98330634E95A.md)
- 2025-01-31 to 2025-04-30 | money | total_equity | 3,279,494,000 United States dollar | superseded | [clm_71AF48870A4F](/claim/clm_71AF48870A4F.md)
- 2025-04-30 to 2025-07-31 | money | cash_and_equivalents | 4,614,153,000 United States dollar | superseded | [clm_4CAD7A6DD7F3](/claim/clm_4CAD7A6DD7F3.md)
- 2025-04-30 to 2025-07-31 | money | quarterly_net_income | -110,207,000 United States dollar | superseded | [clm_C328B750D397](/claim/clm_C328B750D397.md)
- 2025-04-30 to 2025-07-31 | money | quarterly_operating_income | -124,656,000 United States dollar | superseded | [clm_FB76042A595A](/claim/clm_FB76042A595A.md)
- 2025-04-30 to 2025-07-31 | money | quarterly_research_and_development | 334,129,000 United States dollar | superseded | [clm_8F901173B960](/claim/clm_8F901173B960.md)
- 2025-04-30 to 2025-07-31 | money | quarterly_revenue | 1,103,434,000 United States dollar | superseded | [clm_9B968EB26D5B](/claim/clm_9B968EB26D5B.md)
- 2025-04-30 to 2025-07-31 | money | total_assets | 8,720,362,000 United States dollar | superseded | [clm_60402C20003A](/claim/clm_60402C20003A.md)
- 2025-04-30 to 2025-07-31 | money | total_equity | 3,450,877,000 United States dollar | superseded | [clm_657C61BE3699](/claim/clm_657C61BE3699.md)
- 2025-05-29 to 2025-08-21 | money | shares_outstanding | 249,248,174 shares | superseded | [clm_7C505C439CF6](/claim/clm_7C505C439CF6.md)
- 2025-07-31 to 2025-10-31 | money | cash_and_equivalents | 4,972,436,000 United States dollar | superseded | [clm_5449C6798FA3](/claim/clm_5449C6798FA3.md)
- 2025-07-31 to 2025-10-31 | money | quarterly_net_income | -77,675,000 United States dollar | superseded | [clm_BCBCA53C0CFA](/claim/clm_BCBCA53C0CFA.md)
- 2025-07-31 to 2025-10-31 | money | quarterly_operating_income | -112,979,000 United States dollar | superseded | [clm_7A0265B34967](/claim/clm_7A0265B34967.md)
- 2025-07-31 to 2025-10-31 | money | quarterly_research_and_development | 346,668,000 United States dollar | superseded | [clm_E04221800D0C](/claim/clm_E04221800D0C.md)
- 2025-07-31 to 2025-10-31 | money | quarterly_revenue | 1,168,952,000 United States dollar | superseded | [clm_ADBBB57FDCD7](/claim/clm_ADBBB57FDCD7.md)
- 2025-07-31 to 2025-10-31 | money | total_assets | 9,288,859,000 United States dollar | superseded | [clm_4CC090E02D10](/claim/clm_4CC090E02D10.md)
- 2025-07-31 to 2025-10-31 | money | total_equity | 3,756,680,000 United States dollar | superseded | [clm_223CACBED151](/claim/clm_223CACBED151.md)
- 2025-08-21 to 2025-11-25 | money | shares_outstanding | 250,955,140 shares | superseded | [clm_4DA8A994A8AB](/claim/clm_4DA8A994A8AB.md)
- 2025-10-31 to 2026-01-31 | money | cash_and_equivalents | 4,801,083,000 United States dollar | superseded | [clm_63CFE28B58EA](/claim/clm_63CFE28B58EA.md)
- 2025-10-31 to 2026-04-30 | money | quarterly_net_income | -33,997,000 United States dollar | superseded | [clm_B5724BA6677E](/claim/clm_B5724BA6677E.md)
- 2025-10-31 to 2026-04-30 | money | quarterly_operating_income | -69,443,000 United States dollar | superseded | [clm_4066974ADDC6](/claim/clm_4066974ADDC6.md)
- 2025-10-31 to 2026-04-30 | money | quarterly_research_and_development | 347,564,000 United States dollar | superseded | [clm_310A5B4A6F16](/claim/clm_310A5B4A6F16.md)
- 2025-10-31 to 2026-04-30 | money | quarterly_revenue | 1,234,244,000 United States dollar | superseded | [clm_9E7F8F887872](/claim/clm_9E7F8F887872.md)
- 2025-10-31 to 2026-01-31 | money | total_assets | 9,965,347,000 United States dollar | superseded | [clm_E39B35363343](/claim/clm_E39B35363343.md)
- 2025-10-31 to 2026-01-31 | money | total_equity | 4,016,497,000 United States dollar | superseded | [clm_EAA359C6678A](/claim/clm_EAA359C6678A.md)
- 2025-11-25 to 2026-05-28 | money | shares_outstanding | 252,098,440 shares | superseded | [clm_063E1918679D](/claim/clm_063E1918679D.md)

## 2026

- 2026-01-31 to 2026-04-30 | money | cash_and_equivalents | 5,230,125,000 United States dollar | superseded | [clm_0442E937E365](/claim/clm_0442E937E365.md)
- 2026-01-31 | money | net_income | -162,502,000 United States dollar | valid | [clm_B89CA5F73B76](/claim/clm_B89CA5F73B76.md)
- 2026-01-31 | money | operating_income | -293,292,000 United States dollar | valid | [clm_C563031FB9EB](/claim/clm_C563031FB9EB.md)
- 2026-01-31 | money | research_and_development | 1,384,770,000 United States dollar | valid | [clm_CE8224A13952](/claim/clm_CE8224A13952.md)
- 2026-01-31 | money | revenue | 4,812,005,000 United States dollar | valid | [clm_D12915DACC33](/claim/clm_D12915DACC33.md)
- 2026-01-31 to 2026-04-30 | money | total_assets | 11,086,684,000 United States dollar | superseded | [clm_24EED00C3A2A](/claim/clm_24EED00C3A2A.md)
- 2026-01-31 to 2026-04-30 | money | total_equity | 4,428,390,000 United States dollar | superseded | [clm_A5A4BF6BD79D](/claim/clm_A5A4BF6BD79D.md)
- 2026-04-30 to 2026-07-31 | money | cash_and_equivalents | 4,552,801,000 United States dollar | superseded | [clm_F900F187E4DC](/claim/clm_F900F187E4DC.md)
- 2026-04-30 to 2026-07-31 | money | quarterly_net_income | 27,774,000 United States dollar | superseded | [clm_2CDA0E0E7C0B](/claim/clm_2CDA0E0E7C0B.md)
- 2026-04-30 to 2026-07-31 | money | quarterly_operating_income | -30,600,000 United States dollar | superseded | [clm_8024C6AB2A5B](/claim/clm_8024C6AB2A5B.md)
- 2026-04-30 to 2026-07-31 | money | quarterly_research_and_development | 408,326,000 United States dollar | superseded | [clm_4A1DF9F7D466](/claim/clm_4A1DF9F7D466.md)
- 2026-04-30 to 2026-07-31 | money | quarterly_revenue | 1,385,629,000 United States dollar | superseded | [clm_89823CD2BBBB](/claim/clm_89823CD2BBBB.md)
- 2026-04-30 to 2026-07-31 | money | total_assets | 11,270,100,000 United States dollar | superseded | [clm_B972EA638A62](/claim/clm_B972EA638A62.md)
- 2026-04-30 to 2026-07-31 | money | total_equity | 4,633,877,000 United States dollar | superseded | [clm_E26979D4CBF0](/claim/clm_E26979D4CBF0.md)
- 2026-05-28 to 2026-08-20 | money | shares_outstanding | 254,564,820 shares | superseded | [clm_1FB6CA1502A9](/claim/clm_1FB6CA1502A9.md)
- 2026-07-31 | money | cash_and_equivalents | 5,013,847,000 United States dollar | valid | [clm_B14E93A657E4](/claim/clm_B14E93A657E4.md)
- 2026-07-31 | money | quarterly_net_income | 5,306,000 United States dollar | valid | [clm_7E4F9C385446](/claim/clm_7E4F9C385446.md)
- 2026-07-31 | money | quarterly_operating_income | -33,232,000 United States dollar | valid | [clm_5525F3EEB7D6](/claim/clm_5525F3EEB7D6.md)
- 2026-07-31 | money | quarterly_research_and_development | 444,200,000 United States dollar | valid | [clm_AFEAE1868FB2](/claim/clm_AFEAE1868FB2.md)
- 2026-07-31 | money | quarterly_revenue | 1,470,897,000 United States dollar | valid | [clm_ADE8F4808CD6](/claim/clm_ADE8F4808CD6.md)
- 2026-07-31 | money | total_assets | 12,025,001,000 United States dollar | valid | [clm_2B586FE87539](/claim/clm_2B586FE87539.md)
- 2026-07-31 | money | total_equity | 5,101,724,000 United States dollar | valid | [clm_E156D1A32A5F](/claim/clm_E156D1A32A5F.md)
- 2026-08-20 | money | shares_outstanding | 1,023,934,842 shares | valid | [clm_A13144A38B2E](/claim/clm_A13144A38B2E.md)

## undated

- undated | other | cik | 0001535527 | valid | [clm_504C27F509B1](/claim/clm_504C27F509B1.md)
- undated | other | fiscal_year_end | 01-31 | valid | [clm_BF6EEF7367B0](/claim/clm_BF6EEF7367B0.md)
- undated | other | headquarters | Austin | valid | [clm_0E1CFCF1C77A](/claim/clm_0E1CFCF1C77A.md)
- undated | other | listed_on | Nasdaq | valid | [clm_12854E553A0A](/claim/clm_12854E553A0A.md)
- undated | other | registrant_name | CrowdStrike Holdings, Inc. | valid | [clm_F617B085D439](/claim/clm_F617B085D439.md)
- undated | other | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_312C04B26790](/claim/clm_312C04B26790.md)
- undated | other | state_of_incorporation | DE | valid | [clm_BECCB16DF558](/claim/clm_BECCB16DF558.md)
- undated | other | ticker | CRWD | valid | [clm_0EA1CCF40D50](/claim/clm_0EA1CCF40D50.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.